Financial Analysis: Coherus Biosciences Inc (CHRS)’s Ratios Unveil Key Insights

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Coherus Biosciences Inc’s stock clocked out at $1.28, up 5.79% from its previous closing price of $1.21. In other words, the price has increased by $5.79 from its previous closing price. On the day, 6.09 million shares were traded. CHRS stock price reached its highest trading level at $1.39 during the session, while it also had its lowest trading level at $1.19.

Ratios:

To gain a deeper understanding of CHRS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.25.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on August 16, 2024, Downgraded its rating to Neutral and sets its target price to $1.50 from $4 previously.

On November 17, 2023, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $11.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CHRS now has a Market Capitalization of 147472640 and an Enterprise Value of 319658176. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.48. Its current Enterprise Value per Revenue stands at 1.05 whereas that against EBITDA is -2.734.

Stock Price History:

Over the past 52 weeks, CHRS has reached a high of $3.70, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is 39.47%, while the 200-Day Moving Average is calculated to be -21.97%.

Shares Statistics:

It appears that CHRS traded 2.75M shares on average per day over the past three months and 4042240 shares per day over the past ten days. A total of 112.22M shares are outstanding, with a floating share count of 110.58M. Insiders hold about 4.02% of the company’s shares, while institutions hold 66.64% stake in the company. Shares short for CHRS as of 1731628800 were 33038406 with a Short Ratio of 11.47, compared to 1728950400 on 29853066. Therefore, it implies a Short% of Shares Outstanding of 33038406 and a Short% of Float of 33.46.

Most Popular